In: Finance
General Therapeutics Co.’s Revenue in 2018 was $55,000 while its cost of goods sold was $42,000; the company paid $600 in interest while value for depreciation was $6,000.
Also, for 2018 net fixed assets were $25,000 while its current assets were $8,000 and current liabilities were $5,000.
These are the values for 2017: net fixed assets = $19,500, current assets = $6,800 and current liabilities = $4,500. The tax rate is 35%.
Required:
Net Income for 2018 | |
Revenue | 55000 |
Less: cost of goods sold | 42000 |
Gross Profit | 13000 |
Less: Depreciation | 6000 |
EBIT | 7000 |
Less: Finance cost | 600 |
Earning before tax | 6400 |
Tax @ 35% | 2240 |
Net income | $4160 |
Operating Cash Flow = Operating Income + Depreciation – Taxes + Change in Working Capital |
Change in working capital
less: Increase in current asset= -1200
Add: Increase in current liabilities=500
Net change in working capital= -700
=7000+6000-2240-700
=$10060
Cash flow from assets | ||
Operating cash flow | 10060 | |
Less | Net capital spending | -5500 |
Less | Change in working capital | 700 |
= $5260
cash flow from assets represent aggregate of cash flows towards assets . It implies net amount of assets being used in operations.
Cash flow to shareholders comprises of dividend payment. In question dividends payment amount is not given . If we assume no retained earnings. All the earnings after tax are attributable to shareholders, then cash flow to shareholders will be $4160 |